Matt Fuchs lives in Maryland and writes about health, science, and technology. Courtesy Liu In 2021, David Liu couldn’t sleep after the U.S. Food and Drug Administration cleared the first ...

Scientist and biotech cofounder David Liu is one of the pioneers of drugs that can edit DNA. His lab is developing therapy that could prevent Alzheimer's by installing a protective gene.

Prime Medicine is going through a restructuring that includes laying off members of its team, bringing in a new chief executive and reprioritizing its pipeline.

David Liu, the Broad Institute biochemist behind two powerful forms of genome editing, is launching a company focused on delivering gene-editing machinery to precise cells and tissues in the body ...

The technologies developed by Liu’s research team have progressed from human cells ... discussing how she might combine her nucleic acid expertise with the powerful new CRISPR-Cas9 tools. “David was ...

Washington: A revolution is underway in gene editing-- and at its forefront is David Liu, an American molecular biologist whose pioneering work is rewriting the building blocks of life with ...

You can reach Jason on Signal at JasonMast.05. Prime Medicine, founded with gene-editing tech from the lab of star Harvard biochemist David Liu and backed by blue chip investors, made little secre ...

David R. Liu is an inventor on a winning streak. As a young chemist, he quickly mastered techniques for studying life’s most complex molecules and then turned to altering the building blocks of ...